Epidemiology and demographic features
The disease prevalence is heterogeneous and depends on multiple population factors. The overall prevalence of the pathology is about 6 cases per 10,000 children, while the incidence ranges from 1 to 3 new cases per 10,000 children annually.
The disease has distinct gender and geographical features. Girls are genetically and physiologically predisposed to the pathology twice as often as boys. Looking at the geographical gradient, the pathology is registered significantly more often in North America and Europe than in Asian countries.
In the Russian Federation, there is a pronounced age-related dynamic. During adolescence, there is a sharp spike in disease prevalence. Thus, in children under 14 years of age, this figure is approximately 49.6 per 100,000 population. However, upon transition to the 15–17 age group, it increases almost 2.5 times, reaching a value of about 121.5 per 100,000 adolescents.
Etiology and genetic predisposition
The exact root cause of juvenile idiopathic arthritis remains unknown. The pathology is considered a multifactorial disease with a polygenic type of inheritance. Disease manifestation requires the simultaneous combination of genetic immune defects and the influence of certain environmental factors.
Evidence of the significant role of heredity includes the following facts:
- Cases of rheumatoid arthritis are reliably detected more often among first-degree relatives of the proband in populations.
- Twin studies demonstrate high concordance (coincidence of the disease) in monozygotic twins—more than 44%, whereas in dizygotic twins it is only 4%.
At the immunogenetic level, a direct link between the development of the pathology and the carriage of specific major histocompatibility complex (HLA) antigens has been proven. Key markers are class I antigens HLA-A2, B27, B35, as well as class II alleles—DR-5 and DR-8.
The immediate triggering of the pathology is associated with the influence of trigger factors (exogenous and endogenous) that provoke an autoimmune cascade in genetically compromised individuals. Such triggers include:
- Bacterial-viral infections (at the same time, the infectious theory of the root cause is not proven, infection is merely a provoker).
- Physical influences (insolation, hypothermia, injuries).
- Psychological stress and preventive vaccinations.
There is also an alternative hypothesis suggesting the possibility of a primary pathology of the immune system itself, which is capable of triggering an autoimmune process even without an obvious external trigger.
Pathogenesis and articular syndrome
The foundation of pathogenesis is the hyperactivation of cellular and humoral links of the immune system. The process of immune response initiation begins with a foreign or modified own antigen (autoantigen) being captured by macrophages and other antigen-presenting cells (APCs). After processing, APCs present this antigen to naïve T-lymphocytes, signaling the start of an immunopathological reaction.
Next, activation and clonal expansion of T-lymphocytes occur, differentiating into subpopulations, which leads to a massive cytokine cascade:
- Type 1 T-helper cells (Th1) stimulate the synthesis of interleukin-2 (IL-2) and tumor necrosis factor-alpha (TNF-α). These cytokines directly trigger inflammation and destruction processes inside the joint cavity.
- Type 2 T-helper cells (Th2) activate the production of interleukin-6 (IL-6), which is involved in both local inflammation and the development of general systemic reactions.
In addition to immune cells, cells of the joint tissues themselves—fibroblasts and synoviocytes—are actively involved in the synthesis of pro-inflammatory cytokines. This forms a vicious closed circle of progressive local inflammation.
Simultaneously with the cellular link, humoral immunity is involved. Th2-pathway activated T-lymphocytes strongly stimulate B-lymphocytes, which begin excessive synthesis of autoantibodies. It is the formation of autoantibodies that makes a decisive contribution to the development of severe systemic (extra-articular) manifestations of the disease.
Clinically, the articular syndrome is manifested by severe pain (arthralgia) and the development of reversible arthritis. Large joints are predominantly affected.
To memorize the links of pathogenesis, use the mnemonic: "APC presented (presentation) — Th1/Th2 ordered (TNF-α, IL-6) — B-cell fired (autoantibodies) — joint suffered (destruction)"
Class and exam questions
Are viral infections the cause of JIA development?
No, the role of infectious agents as a primary cause has not been proven at present. They are considered solely as triggers that initiate the autoimmune process in genetically predisposed patients.
Which joints are most susceptible to damage in this disease?
Within the framework of articular syndrome in juvenile idiopathic arthritis, large joints are predominantly affected, accompanied by arthralgia and reversible arthritis.
Why is there a spike in the incidence during adolescence?
Although the exact cause is multifactorial, statistics confirm that at 15–17 years of age, the incidence increases by almost 2.5 times, which is associated with the influence of endogenous factors (hormonal changes) and the accumulation of environmental triggers in genetically compromised children.
What else to study on this topic
- Clinical picture of articular syndrome and types of joint deformity
- Systemic (extra-articular) manifestations of juvenile idiopathic arthritis
- The impact of the disease on the growth and physical development processes of the child
- Diagnostic criteria and differential diagnosis with other arthritidis
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Juvenile idiopathic arthritis" and 3,738 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics of «Chapter 9. Rheumatic Diseases»
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.